REMINDER: Zealand Pharma’s Capital Markets Day on December 11, 2025
Press release – No. 17 / 2025
REMINDER: Zealand Pharma’s Capital Markets Day on December 11, 2025
Copenhagen, Denmark, December 1, 2025 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, is hosting a Capital Markets Day in London on December 11, 2025, featuring presentations from management and external experts in obesity and metabolism.
Time: December 11, 2025, from 1.00-5.30pm GMT (2.00-6.30pm CET)
Venue: Goldman Sachs International, Plumtree Court, 2 Stonecutter Street, London EC4A 4AU
Register for in-person or virtual attendance: Registration | Zealand Pharma Capital Markets Day
A replay of the webcast will be archived on the company’s website following the presentation.
Zealand Pharma speakers:
- Adam Steensberg, Chief Executive Officer
- Henriette Wennicke, Chief Financial Officer
- David Kendall, Chief Medical Officer
- Eric Cox, Chief Commercial Officer
- Utpal Singh, Chief Scientific Officer
External experts:
- Dr. Carel Le Roux, MBChB, MSC, FRCP, FRCPath, PhD, Professor of Experimental Pathology at University College Dublin
- Jonathan Roth, PhD, Metabolic researcher and pioneer in amylin-leptin biology
- Louis J. Aronne, MD, FACP, DABOM, Sanford I. Weill Professor of Metabolic Research at Weill Cornell Medical College
About Zealand Pharma
Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand Pharma have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products.
Zealand Pharma was founded in 1998 and is headquartered in Copenhagen, Denmark, with a presence in the U.S. For more information about Zealand Pharma’s business and activities, please visit www.zealandpharma.com.
Contacts
Adam Lange (Investors)
Vice President, Investor Relations
Zealand Pharma
Email: alange@zealandpharma.com
Neshat Ahmadi (Investors)
Investor Relations Manager
Zealand Pharma
Email: neahmadi@zealandpharma.com
Rachel James-Owens (Media)
Vice President, Corporate Communications and Media Relations
Zealand Pharma
RJamesOwens@zealandpharma.com
Amber Fennell, Jessica Hodgson, Sean Leous (Media)
ICR Healthcare
ZealandPharma@icrhealthcare.com
+44 (0) 7739 658 783
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
